Figure 2
From: Clinical application of tumor volume in advanced nasopharyngeal carcinoma to predict outcome
Analysis of the subgroup with GTVprn ≧ 13 ml revealed better overall survival after ≧ 4 cycles of chemotherapy than after less than 4 cycles. (p < 0.05).